---
schema_version: "secwatch.filing_event.v1"
accession: "0001607062-22-000464"
form_type: "8-K"
ticker: "RGBP"
cik: "0001589150"
company_name: "Regen BioPharma Inc"
filed_at: "2022-07-20T23:59:59+00:00"
generated_at: "2026-06-24T11:17:58.411110+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Regen Biopharma issues 54.5M shares to retire $180,552 convertible note with Coventry

## Summary
- Issued 54,514,492 common shares to Coventry Enterprises LLC to satisfy $180,552 of convertible indebtedness.
- Principal and accrued interest on $1.5M promissory note now $0 as of July 19, 2022.
- Shares issued under Section 4(a)(2) exemption; no underwriter or commission paid.
- Significant dilution for existing shareholders; all outstanding convertible debt now retired.

## SEC filing metadata
- accession: 0001607062-22-000464
- form_type: 8-K
- ticker: RGBP
- cik: 0001589150
- company_name: Regen BioPharma Inc
- filed_at: 2022-07-20T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1589150/000160706222000464/0001607062-22-000464-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1589150/000160706222000464/rgbp072022form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001607062-22-000464
- JSON: https://secwatch.observer/filing/0001607062-22-000464.json
- Plain text: https://secwatch.observer/filing/0001607062-22-000464.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.